JRCT ID: jRCT1080220077
Registered date:08/09/2005
Basic Information
Recruitment status | other |
---|---|
Health condition(s) or Problem(s) studied | Gastric ulcer with Helicobacter pylori infection |
Date of first enrollment | 08/09/2005 |
Target sample size | 300 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Polaprezinc INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | The time for healing of gastric ulcer |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | |
Include criteria | Inclusion criteria -active gastric ulcer -single gastric ulcer Exclusion criteria -the patients who are eradicated Helicobacter pylori before |
Exclude criteria |
Related Information
Primary Sponsor | Zeria Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050077 |
Contact
Public contact | |
Name | |
Address | kaihatu@zeria.co.jp |
Telephone | |
Affiliation | ZERIA Pharmaceutical Co.,Ltd |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |